"El Hospital Universitari Sagrat Cor es un centro hospitalario fundado en las décadas de los 60/70 que ofrece todas las especialidades médico-quirúrgicas y desarrolla actividades asistenciales, docentes y de investigación. Quirónsalud, que gestiona este centro desde 2011, ha abordado importantes reformas infraestructurales en las áreas de urgencias, consultas externas y hospitalización con el objetivo de mejorar la confortabilidad, modernizar los espacioes e incorporar nuevas dotaciones tecnológicas que contribuyen a la mejora en la atención al paciente."

During the past decade, Hospital Universitari Sagrat Cor conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitari Sagrat Cor" #1 sponsor was "Population Health Research Institute" with 2 trials, followed by "Bayer" with 1 trials sponsored, "Consorcio Centro de Investigación Biomédica en Red (CIBER)" with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Ferrer Internacional S.A." with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitari Sagrat Cor" #1 collaborator was "Barcelona Supercomputing Center" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Carlos III Health Institute" with 1 trials as a collaborator, "Hamilton Health Sciences Corporation" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitari Sagrat Cor" are "Acute Respiratory Distress Syndrome" (1 trials), "Acute Respiratory Failure" (1 trials), "Acute Stroke" (1 trials), "Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Hospital Universitari Sagrat Cor" in a lesser frequency.

Most popular intervention types in "Hospital Universitari Sagrat Cor" are "Drug" (6 trials), "Procedure" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Accelerated medical clearance and surgery" (1 trials), "Aflibercept(BAY86-5321, Eylea)" (1 trials), "Bemiparina Sodica" (1 trials) and "Chemotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitari Sagrat Cor" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Universitari Sagrat Cor". 1 are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Hospital Universitari Sagrat Cor, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitari Sagrat Cor, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".